Floatz logo

Udenafil

Erectile Dysfunction

Seoul National University HospitalSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
81/ 100

Competitive context

20 Active assets in the Erectile Dysfunction cohort.

Asset / SponsorPhaseRating
Tadalafil
Surgical Outcomes Research Centre (SOuRCe)
Phase 4BB
Sildenafil
The Netherlands Cancer Institute
Phase 4BB
BAY38-9456
Bayer
Phase 4BB
Indocyanine Green
Ankara University
Phase 4BB
Ningmitai
Xintian Pharmaceutical
Phase 4BB

View all 38 →

Same molecule, other indications

Udenafil is also rated in:

rectal carcinomaDormant
BB
Indicative ·
66 / 100
View asset →
prostate cancerDormant
BB
Indicative ·
65 / 100
View asset →
sigmoid colon cancerDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →